Literature DB >> 9373454

Increased incidence of neoplasia in females with acromegaly.

N W Cheung1, S C Boyages.   

Abstract

OBJECTIVE: Some studies have indicated an increased incidence of neoplasia, particularly breast and colon, in acromegaly. We have determined the incidence of benign and malignant neoplasms in an Australian population of patients with acromegaly.
DESIGN: Retrospective review, with comparison against cancer data for the local population obtained from a State Cancer Registry. PATIENTS: Fifty patients with documented acromegaly.
RESULTS: There were 7 cases of malignancy (2 in men, 5 in women) in the period of follow-up (435 patient years). With logistic regression analysis, there was a relative risk of malignancy, of 1.2 (95% confidence interval 0.31-5.0) for men (P = 0.8) and 4.3 (95% confidence interval 1.7-10.5) for women (P = 0.001), when compared to the local population. There were 2 cases of breast and renal carcinoma, and one each of prostatic, colonic and parotid carcinoma. Of the most common benign tumours 35% of patients had thyroid nodules, 10% had colonic polyps and 6% had nasal polyps.
CONCLUSION: The incidence of malignancy was found to be increased in female patients with acromegaly in this series. Routine screening procedures for malignancy, particularly in female patients, should therefore be considered.

Entities:  

Mesh:

Year:  1997        PMID: 9373454     DOI: 10.1046/j.1365-2265.1997.2561053.x

Source DB:  PubMed          Journal:  Clin Endocrinol (Oxf)        ISSN: 0300-0664            Impact factor:   3.478


  9 in total

Review 1.  Growth hormone and prostate cancer: guilty by association?

Authors:  A Grimberg; P Cohen
Journal:  J Endocrinol Invest       Date:  1999       Impact factor: 4.256

Review 2.  Epidemiology of acromegaly.

Authors:  I M Holdaway; C Rajasoorya
Journal:  Pituitary       Date:  1999-06       Impact factor: 4.107

3.  Prevalence of thyroid diseases in patients with acromegaly: results of an Italian multi-center study.

Authors:  M Gasperi; E Martino; L Manetti; M Arosio; S Porretti; G Faglia; S Mariotti; A M Colao; G Lombardi; R Baldelli; F Camanni; A Liuzzi
Journal:  J Endocrinol Invest       Date:  2002-03       Impact factor: 4.256

4.  Risk of colorectal neoplasm in patients with acromegaly: a meta-analysis.

Authors:  Theodoros Rokkas; Dimitrios Pistiolas; Panos Sechopoulos; Georgios Margantinis; Georgios Koukoulis
Journal:  World J Gastroenterol       Date:  2008-06-14       Impact factor: 5.742

Review 5.  Acromegaly: re-thinking the cancer risk.

Authors:  Siobhan Loeper; Shereen Ezzat
Journal:  Rev Endocr Metab Disord       Date:  2008-03       Impact factor: 6.514

6.  Adrenal morpho-functional alterations in patients with acromegaly.

Authors:  C Scaroni; R Selice; S Benedini; E De Menis; M Arosio; C Ronchi; M Gasperi; L Manetti; G Arnaldi; B Polenta; M Boscaro; N Albiger; E Martino; F Mantero
Journal:  J Endocrinol Invest       Date:  2008-07       Impact factor: 4.256

Review 7.  Oncological complications of excess GH in acromegaly.

Authors:  Susan M Webb; Felipe Casanueva; John A H Wass
Journal:  Pituitary       Date:  2002-01       Impact factor: 4.107

8.  Disruption of Growth Hormone Receptor Signaling Abrogates Hepatocellular Carcinoma Development.

Authors:  Abedul Haque; Vishal Sahu; Jamie Lynne Lombardo; Lianchun Xiao; Bhawana George; Robert A Wolff; Jeffrey S Morris; Asif Rashid; John J Kopchick; Ahmed O Kaseb; Hesham M Amin
Journal:  J Hepatocell Carcinoma       Date:  2022-08-15

9.  Case Report: A case report of acromegaly associated with primary aldosteronism.

Authors:  Joanna Matrozova; Silvia Vandeva; Sabina Zacharieva
Journal:  F1000Res       Date:  2014-02-14
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.